Anti-SERPING1 / C1 Inhibitor Antibody
Sheep Anti Human Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, IHC-P, E, IP, ID, Flo |
---|---|
Primary Accession | P05155 |
Predicted | Human |
Host | Sheep |
Clonality | Polyclonal |
Calculated MW | 55154 Da |
Dilution | ELISA, Flo, ID, IHC-P (5 µg/ml), IP, WB |
Gene ID | 710 |
---|---|
Alias Symbol | SERPING1 |
Other Names | SERPING1, C1-inhibiting factor, C1IN, C1 Inh, C1-INH, C1INH, C1NH, C1 Inhibitor, HAE1, HAE2, Plasma protease C1 inhibitor, C1 esterase inhibitor, Serpin G1 |
Target/Specificity | Human C1 Inhibitor |
Reconstitution & Storage | Immunoaffinity purified |
Precautions | Anti-SERPING1 / C1 Inhibitor Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | SERPING1 |
---|---|
Synonyms | C1IN, C1NH |
Function | Activation of the C1 complex is under control of the C1- inhibitor. It forms a proteolytically inactive stoichiometric complex with the C1r or C1s proteases. May play a potentially crucial role in regulating important physiological pathways including complement activation, blood coagulation, fibrinolysis and the generation of kinins. Very efficient inhibitor of FXIIa. Inhibits chymotrypsin and kallikrein. |
Cellular Location | Secreted. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.